One of the biggest complaints about the U.S. regulatory system is that the clinical trials required to prove safety and efficacy are prohibitively expensive.

But could technology help to justify that cost or reduce costly errors related to clinical trial design? Or, better yet, eliminate clinical trials completely?

Click here to read the full story